Navigation Links
Adult Glioblastoma: Strategies, Challenges, and Opportunities

A Complimentary Continuing Education Lecture Series for Healthcare


HADDON HEIGHTS, N.J., March 24 /PRNewswire/ -- Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean length of survival in patients is less than one year.

Recent clinical trials have shown that combining surgery, radiation therapy and chemotherapy extends survival in a subset of patients, particularly when the chemotherapeutic agent temozolomide is included in the treatment approach. Other potentially promising therapies for glioblastoma under investigation include regional drug administration, targeted biological therapies, vaccines, and genomic profiling. As research continues, new agents for adult glioblastoma are expected to further extend survival.

To address the need for current education on glioblastoma, treatment strategies, challenges, and emerging therapies, Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary live educational lectures in institutions across the United States, as well as an online educational activity consisting of a virtual lecture presentation.

The Course Director for this continuing education opportunity is Dr. Marc C. Chamberlain, Professor of Neurology at the University of Washington and expert in the development of clinical trials for primary brain tumors. All lectures will be presented by experts in the treatment of glioblastoma. Continuing education credit will be offered for physicians, pharmacists and nurses.

Healthcare professionals can schedule a live lecture at their institution by contacting RMEI:


Toll-free Phone: 1-866-770-7634, ext. 337


This continuing education opportunity is jointly sponsored by Robert Michael Educational Institute LLC and Postgraduate Institute of Medicine and is supported by an educational grant from Schering-Plough.

Robert Michael Educational Institute LLC is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers, patients, and caregivers. Our mission is to design programs that improve diagnosis and treatment through a variety of educational programming such as national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Rheumatoid Arthritis Drug Works for Adults, Children
2. Research on consequences: Hyperactive girls face problems as adults
3. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
4. Cystic Fibrosis Foundation announces $5 million initiative to enhance care for adults with CF
5. Cystic Fibrosis Foundation Announces $5 Million Initiative to Enhance Care for Adults with CF - as Lifespan Increases
6. Depression: the symptoms in children are not like in adults
7. Dont Prescribe Antibiotics for Adult Sinus Woes
8. Rate of escalator injuries to older adults has doubled
9. Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life
10. The Attention Deficit Disorder Association and The HealthCentral Network Form Alliance to Develop New Online Resources for Adult ADHD
11. Emergency on-field treatment for neck injuries in young sports athletes no different than adults
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... In an ... Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of ... and surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
Breaking Medicine Technology: